Clindamycin Hydrochloride Capsule
Product Images NDC 0904-7194

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 0904-7194). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clindamycin Str)

Chemical Structure (Clindamycin Str)
Chemical structure diagram of Clindamycin Hydrochloride showing its molecular components and arrangement, including the hydrochloride (HCl) group. The molecular formula C18H33ClN2O5 and molecular weight 461.45 are noted at the bottom.*
FDA Label Image

300mg Carton Label (97a9034b 2c9f 48a0 95a0 62e60c49329c 00)

300mg Carton Label (97a9034b 2c9f 48a0 95a0 62e60c49329c 00)
Label for Clindamycin Hydrochloride 300 mg capsules, USP, oral dosage form by Major Pharmaceuticals. The label shows a bottle unit dose with 100 capsules (10 x 10) and includes dosing information, storage instructions, and distributor details. The NDC is 0904-7194-61, and the product is Rx only, made in India and packaged by Major Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.